ImmunoGen CEO Mark Enyedy's 2021 pay jumps 62% to $7.4M
ImmunoGen reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
ImmunoGen reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, five ImmunoGen executives received on average a compensation package of $3.2M, a 56% increase compared to previous year.
Average pay of disclosed executives at ImmunoGen
Mark J. Enyedy, Chief Executive Officer, received $7.4M in total, which increased by 62% compared to 2020. 83% of Enyedy's compensation, or $6.2M, was in option awards. Enyedy also received $499K in non-equity incentive plan, $735K in salary, as well as $9.7K in other compensation.
For fiscal year 2021, the median employee pay was $296,859 at ImmunoGen. Therefore, the ratio of Mark J. Enyedy's pay to the median employee pay was 25 to one.
Kristen Harrington-Smith, Senior Vice President and Chief Commercial Officer, received a compensation package of $2.8M. 64% of the compensation package, or $1.8M, was in option awards.
Anna Berkenblit, Chief Medical Officer, earned $2.5M in 2021, a 57% increase compared to previous year.
Stacy Coen, Senior Vice President and Chief Business Officer, received $1.6M in 2021, which increases by 22% compared to 2020.
Susan Altschuller, Chief Financial Officer, earned $1.5M in 2021, a 8% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2022.